The difference is any other pharma company could file patents on other applications of ATL1102 (e.g. like for treating Alzheimers) before ANP and own that use of ATL1102 (assuming it’s granted).
anp chart, page-726
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $15.4K | 152.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 108874 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 296558 | 5 |
View Market Depth
| Last trade - 10.17am 03/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |